magtv, I agree, it appears that Pfizer is looking at the Roslin pluripotent stem cells but not currrently looking at the ACTC hESCs. However, they may well be hoping to work their way over to the ACTC cells.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.